Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

  • Home
  • Blog
  • Latest Post
  • Product Catalog
b77e8639-129a-40c6-b128-527621a55c3a (1)
FDA Approves Expanded Labeling of Farapulse PFA System for Persistent Atrial Fibrillation
Health
  • July 14, 2025
By AdminPrabadin - 11 hours ago
0

The expanded instructions for use labeling expand on the Farawave and Farawave Nav Pulsed Field Ablation (PFA) catheters.

Previous article

Experts Weigh In on What FDA’s Removal of REMS for CAR T Means for Patients, Pharmacists

Next article

Independent Pharmacy Owners Harness Grassroots Strategies and Technology to Build Stronger Communities

AdminPrabadin
administrator

Related Articles

Health

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

  • July 14, 2025
Health

Independent Pharmacies Embrace AI to Solve Staffing Challenges…

  • July 14, 2025
Health

Adjuvant Trastuzumab Emtansine Plus Trastuzumab Improved Disease-Free, Overall…

  • July 14, 2025
© Copyright Barta 2018. Designed and Developed by Komarca Soft